CA2907494C - Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders - Google Patents

Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders Download PDF

Info

Publication number
CA2907494C
CA2907494C CA2907494A CA2907494A CA2907494C CA 2907494 C CA2907494 C CA 2907494C CA 2907494 A CA2907494 A CA 2907494A CA 2907494 A CA2907494 A CA 2907494A CA 2907494 C CA2907494 C CA 2907494C
Authority
CA
Canada
Prior art keywords
subject
asd
activity
stimulus
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2907494A
Other languages
English (en)
French (fr)
Other versions
CA2907494A1 (en
Inventor
Timothy P.L. Roberts
James Christopher EDGAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Children's Hospital of Philadelphia
Original Assignee
Children's Hospital of Philadelphia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Children's Hospital of Philadelphia filed Critical Children's Hospital of Philadelphia
Publication of CA2907494A1 publication Critical patent/CA2907494A1/en
Application granted granted Critical
Publication of CA2907494C publication Critical patent/CA2907494C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/242—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents
    • A61B5/245—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals
    • A61B5/246—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals using evoked responses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA2907494A 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders Active CA2907494C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361787077P 2013-03-15 2013-03-15
US61/787,077 2013-03-15
PCT/US2014/030138 WO2014145382A2 (en) 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders

Publications (2)

Publication Number Publication Date
CA2907494A1 CA2907494A1 (en) 2014-09-18
CA2907494C true CA2907494C (en) 2022-10-04

Family

ID=51538466

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2907494A Active CA2907494C (en) 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders

Country Status (6)

Country Link
US (1) US10342480B2 (enExample)
EP (1) EP2967405A4 (enExample)
JP (1) JP6585030B2 (enExample)
AU (1) AU2014233048B2 (enExample)
CA (1) CA2907494C (enExample)
WO (1) WO2014145382A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018194959A1 (en) * 2017-04-17 2018-10-25 Miron Oren Auditory brainstem response for autism prediction
EP3684463B1 (en) 2017-09-19 2025-05-14 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US11318277B2 (en) 2017-12-31 2022-05-03 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11426073B2 (en) * 2018-04-27 2022-08-30 Washington University Imaging nerve function and pathologies using diffusion basis spectrum imaging
US11452839B2 (en) 2018-09-14 2022-09-27 Neuroenhancement Lab, LLC System and method of improving sleep
US11103171B2 (en) * 2018-10-23 2021-08-31 BlackThor Therapeutics, Ine. Systems and methods for screening, diagnosing, and stratifying patients
FI20185893A1 (fi) * 2018-10-23 2020-04-24 Elekta Oy Päähän asennettava laitteisto
US12402828B2 (en) 2019-03-13 2025-09-02 The Children's Hospital Of Philadelphia Methods for the detection of brain injury
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
WO2021096946A1 (en) * 2019-11-15 2021-05-20 The University Of Chicago Cancer detection based on four quadrant mapping and matrix analysis of image data
US12521053B2 (en) * 2022-01-05 2026-01-13 Tdk Corporation Methods and devices for electromagnetic measurements from ear cavity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2540295A1 (en) * 2011-06-27 2013-01-02 Centre national de la recherche scientifique Compositions for the treatment of Fragile X syndrome

Also Published As

Publication number Publication date
JP6585030B2 (ja) 2019-10-02
EP2967405A2 (en) 2016-01-20
US20160022207A1 (en) 2016-01-28
AU2014233048B2 (en) 2019-01-03
WO2014145382A8 (en) 2014-12-31
WO2014145382A2 (en) 2014-09-18
US10342480B2 (en) 2019-07-09
WO2014145382A3 (en) 2014-10-30
EP2967405A4 (en) 2017-01-11
JP2016519595A (ja) 2016-07-07
CA2907494A1 (en) 2014-09-18
AU2014233048A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
AU2014233048B2 (en) Magnetoencephalography biomarkers of GABA-B agonist drug activity in autism spectrum disorders
Edgar et al. Neuromagnetic oscillations predict evoked-response latency delays and core language deficits in autism spectrum disorders
Roberts et al. Maturational differences in thalamocortical white matter microstructure and auditory evoked response latencies in autism spectrum disorders
Huneau et al. Altered dynamics of neurovascular coupling in CADASIL
Edgar et al. Cortical thickness as a contributor to abnormal oscillations in schizophrenia?
Hata et al. Functional connectivity assessed by resting state EEG correlates with cognitive decline of Alzheimer’s disease–An eLORETA study
Grützmann et al. Presupplementary motor area contributes to altered error monitoring in obsessive-compulsive disorder
Wang et al. Resting state EEG abnormalities in autism spectrum disorders
Peters et al. Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity
Jacobs et al. Hemodynamic responses to interictal epileptiform discharges in children with symptomatic epilepsy
Shin et al. Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography
Hartings et al. Spreading depression in continuous electroencephalography of brain trauma
Zhou et al. A modality‐specific dysfunction of pain processing in schizophrenia
Boshra et al. On the time-course of functional connectivity: theory of a dynamic progression of concussion effects
Wu et al. Resting-state electroencephalography of neural oscillation and functional connectivity patterns in late-life depression
Baumgarten et al. Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients
Juan et al. Distinct signatures of loss of consciousness in focal impaired awareness versus tonic-clonic seizures
Chen Cortical representation of pain and touch: evidence from combined functional neuroimaging and electrophysiology in non-human primates
De Pieri et al. Resting-state EEG and MEG gamma frequencies in schizophrenia: a systematic review and exploratory power-spectrum meta-analysis
Bartolomeo et al. Relationship of auditory electrophysiological responses to magnetic resonance spectroscopy metabolites in Early Phase Psychosis
Jacobs et al. Negative BOLD in default-mode structures measured with EEG-MREG is larger in temporal than extra-temporal epileptic spikes
Staffen et al. Brain activation disturbance for target detection in patients with mild cognitive impairment: an fMRI study
Akkol et al. Intracranial electroencephalography reveals selective responses to cognitive stimuli in the periventricular heterotopias
Orgo et al. Brain functional connectivity in depression: Gender differences in EEG
Kollewe et al. Magnetic resonance imaging in amyotrophic lateral sclerosis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190313

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241218

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241219

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20241219

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251202

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251202